Aquarius Pilot Study to Evaluate the New Axonics Trial System
Axonics, Inc. · NCT07335484
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Not accepted (a condition is required)
- Study type
- Interventional · Not applicable
- Target enrollment
- 75
- US sites recruiting
- 3
- Study start
- April 30, 2026
- Record last updated
- October 13, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Evaluation of the new Axonics External Trial System (ETS-02) in patients with overactive bladder (OAB) and/or fecal incontinence (FI).
Being studied: Axonics External Trial System (ETS)
Conditions: Urinary Urge Incontinence (UUI); Urinary Frequency (UF); Fecal Incontinence (FI); Overactive Bladder (OAB)
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- 18 years or older
- Provides written informed consent prior to trial procedures
- Primary indication of OAB (UUI/UF) or chronic FI who are considered candidates for an Axonics PNE procedure as assessed by the physician per product IFU
Exclusion Criteria
- Any participant that the study Investigator deems to be a poor candidate for any reason, including, but not limited to, inability to complete a baseline bladder or bowel diary or to be compliant with study visits
- Planned changes to current regimen of medications during the trial period that could impact bladder or bowel function
- Current urinary tract mechanical obstruction (e.g., benign prostatic enlargement or urethral stricture)
- Current symptomatic urinary tract infection (UTI)
Recruiting US locations
University of Birmingham, Alabama
Birmingham, AL 35294
Site contact: Alisha Hitt
Atrium Health - Navicent
Macon, GA 31201
Site contact: Jennifer Crawford, PhD
Southern Urogynecology
West Columbia, SC 29169
Site contact: Tina McGready
Study contacts (from the official record)
- Erum Shaikh · 657.626.4310 · Erum.Shaikh@bsci.com
- Gita Ghadimi, OD · 949-981-4366 · Gita.Ghadimi@bsci.com
Similar studies in Alabama
All women’s health studies in Alabama →- Recruiting
A Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Evaluation (RECIPE)
Valencia Technologies Corporation
- Location
- Homewood, AL + 18 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
Biweekly Long-term Occidiofungin Study for Suppression of Mycotic Recurrence
Sano Chemicals Inc
- Location
- Birmingham, AL
- Eligibility basics
- Ages 18–65 · Women only
- Recruiting
VALOR: Vaginal Atrophy & Long-term Observation of Recovery
Stratpharma AG
- Location
- Birmingham, AL + 5 other US sites
- Eligibility basics
- Ages 18+ · Women only
- RecruitingPhase 3
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
Sumitomo Pharma Switzerland GmbH
- Location
- Mobile, AL + 101 other US sites
- Eligibility basics
- Ages 18–50 · Women only